Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
2.
Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ulla Ruotsalainen U, Heikki Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. J Nucl Med. 1993;34:1–6.PubMed
3.
Hasselbalch SG, Knudsen GM, Videbaek C, Pinborg LH, Schmidt JF, Holm S, et al. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes. 1999;86:1915–21.CrossRef
4.
5.
Bender D, Munk OL, Feng HQ, Keiding S. Metabolites of (18)F-FDG and 3-O-(11)C-methylglucose in pig liver. J Nucl Med. 2001;42:1673–8.PubMed
6.
Keramida G, Potts J, Bush J, Dizdarevic S, Peters AM. Hepatic steatosis is associated with increased hepatic FDG uptake. Eur J Radiol. 2014;83:751–5.CrossRefPubMed
7.
Iozzo P, Geisler F, Oikonen V, Mäki M, Takala T, Solin O, et al. Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET study. J Nucl Med. 2003;44:682–9.PubMed
8.
Green LA, Gambhir SS, Srinivasan A, Banerjee PK, Hoh CK, Cherry SR, et al. Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose. J Nucl Med. 1998;39:729–34.PubMed
9.
Namba H, Nakagawa K, Iyo M, Fukushi K. Irie T. A simple method for measuring glucose utilization of insulin-sensitive tissues by using the brain as a reference. Eur J Nucl Med. 1994;21:228–31.CrossRefPubMed
Metadata
Title
Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
Authors
A. Michael Peters
Georgia Keramida
Deborah Pencharz
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-4086-0

Other articles of this Issue 12/2018

European Journal of Nuclear Medicine and Molecular Imaging 12/2018 Go to the issue

Original Article

68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients

Original Article

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)

Editorial

Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?

Reply

Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis

Original Article

FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients

Original Article

Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription